Remove Clinic Management Remove Patient Care Remove Seminar
article thumbnail

The evolution of durvalumab in NSCLC care

Hospital Pharmacy Europe

That’s been driven by advancements in targeted therapies, immunotherapy and the more personalised approach to patient care,’ he says. This could include educational initiatives such as workshops, seminars and webinars focused on the role of durvalumab in non-small cell lung cancers. I’m optimistic we’ll see that.’